Heron Therapeutics, INC. /De/ (HRTX) — SC 13G/A Filings
All SC 13G/A filings from Heron Therapeutics, INC. /De/. Browse 4 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (4)
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Vanguard Group Amends Heron Therapeutics Stake to 9.9%
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended Schedule 13G/A on February 13, 2024, disclosing its ownership in Heron Therapeutics Inc. As of Dec -
Franklin Resources Amends Heron Therapeutics Stake as of Dec 31, 2023
— Feb 6, 2024
Franklin Resources, Inc. has filed an amendment (SC 13G/A) to its Schedule 13G, indicating a change in its ownership stake in Heron Therapeutics, Inc. /DE/ as o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX